The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways

Hang Li(University of Hong Kong - Shenzhen Hospital), Lihong Ye(Nankai University), Kai Ye(Southwest University of Science and Technology), Yu Shen(Nankai University), Qian Liu(Nankai University), Runping Fang(Virginia Commonwealth University), Zhen Wang(Xi'an Jiaotong University), Hui Shi(Soochow University), Mian Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoli Cai(Wuhan University of Science and Technology), Saijun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Weiying Zhang(Jianghan University)
Acta Pharmacologica Sinica
September 4, 2018
Cited by 25


Related Papers